Identification |
Name: | 1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,hydrochloride (1:1), (3S)- |
Synonyms: | 1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride, (3S)- (9CI);1H-1-Benzazepine-1-acetic acid,3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride, [S-(R*,R*)]-;CGS 14824A;CGS14824A HCl;Lotensin;Lotension; |
CAS: | 86541-74-4 |
Molecular Formula: | C24H29ClN2O5 |
Molecular Weight: | 460.95046 |
InChI: | InChI=1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19-,20-;/m0./s1 |
Molecular Structure: |
|
Properties |
Water Solubility: | DMSO: ~34 mg/mL, soluble |
Solubility: | DMSO: ~34 mg/mL, soluble |
Appearance: | Crystalline Solid |
Specification: | Crystalline Solid usageEng:Used as an antihypertensive Safety Statements:22-24/25 22:Do not breathe dust 24/25:Avoid contact with skin and eyes |
Biological Activity: | Non-peptide angiotensin-converting enzyme (ACE) inhibitor. Reduces blood pressure and myocardial hypertrophy in spontaneous hypertensive rats. |
Color: | white |
Usage: | Used as an antihypertensive |
Safety Data |
|
|